Core B Core B, the Biochemical and Metabolic Services Core, will assist the projects in processes where specialized equipment and experienced personnel can greatly increase the efficiency and accuracy of results beyond that which could be achieved by the individual projects. These processes include proteomic, biochemical and metabolic assays carried out in vitro and in vivo as well as the development of genetic constructs to alter expression of candidate genes. The services performed by the Biochemical and Metabolic Profiling Core can be broken down into six broad categories: 1) Analysis of plasma samples; 2) Analysis of tissue samples; 3) In vivo metabolic/physiologic tests 4) Expression modulation to validate candidate genes 5) Proteomic analysis and 6) Specialized biochemical and metabolic analysis designed to address specific project needs. The methods and assays employed have all been fully implemented and used successfully by our experienced personnel. This core strongly interacts with all the projects and with Core C (the Database, Computing and Statistics Core ) and has served as a vital component of the PPG for the past 20 years.

Public Health Relevance

Core B Core B assists the projects in processes where specialized equipment and experienced personnel can greatly increase the efficiency and accuracy of results beyond that which could be achieved by the individual projects. These processes include biochemical and metabolic assays carried out in vitro and in vivo as well as the development of genetic constructs to alter expression of candidate genes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL028481-35
Application #
9689503
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Liu, Lijuan
Project Start
Project End
2021-04-30
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
35
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Lang, Jennifer M; Pan, Calvin; Cantor, Rita M et al. (2018) Impact of Individual Traits, Saturated Fat, and Protein Source on the Gut Microbiome. MBio 9:
Cherlin, Svetlana; Wang, Maggie Haitian; Bickeböller, Heike et al. (2018) Detecting responses to treatment with fenofibrate in pedigrees. BMC Genet 19:64
Park, Shuin; Ranjbarvaziri, Sara; Lay, Fides D et al. (2018) Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis. Circulation 138:1224-1235
Roberts, Adam B; Gu, Xiaodong; Buffa, Jennifer A et al. (2018) Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med 24:1407-1417
Zhu, W; Buffa, J A; Wang, Z et al. (2018) Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. J Thromb Haemost 16:1857-1872
Lee, Jessica M; Ong, Jessica R; Vergnes, Laurent et al. (2018) Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants. J Lipid Res 59:429-438
Miao, Zong; Alvarez, Marcus; Pajukanta, Päivi et al. (2018) ASElux: an ultra-fast and accurate allelic reads counter. Bioinformatics 34:1313-1320
Kurt, Zeyneb; Barrere-Cain, Rio; LaGuardia, Jonnby et al. (2018) Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease. Biol Sex Differ 9:46
Orozco, Luz D; Farrell, Colin; Hale, Christopher et al. (2018) Epigenome-wide association in adipose tissue from the METSIM cohort. Hum Mol Genet 27:1830-1846
Chella Krishnan, Karthickeyan; Kurt, Zeyneb; Barrere-Cain, Rio et al. (2018) Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease. Cell Syst 6:103-115.e7

Showing the most recent 10 out of 518 publications